| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/11/2008 | US20080305114 Human antibodies that bind human il-12 and methods for producing |
| 12/11/2008 | US20080305113 Pharmaceutical Composition for Preventing or Treating Chronic Graft-Versus-Disease Comprising Anti-CD137 Monoclonal Antibody |
| 12/11/2008 | US20080305112 raising an antibody specific for Chlamydia trachomatis elementary bodies (EB) in which a protein of the present invention is administered to a patient |
| 12/11/2008 | US20080305111 Anti-C35 antibodies for treating cancer |
| 12/11/2008 | US20080305110 Novel Ligand of G Protein Coupled Receptor Protein and Use Thereof |
| 12/11/2008 | US20080305109 Method of passive immunization |
| 12/11/2008 | US20080305108 Peptides of Il1 Beta and Tnf Alpha and Method Treatment |
| 12/11/2008 | US20080305107 Targeting slow-growing, relatively mutationally spared cancer stem line; early cancer treatment and reduce the likelihood of clinical relapse |
| 12/11/2008 | US20080305106 Novel Gene Disruptions, Composition and Methods Relating Thereto |
| 12/11/2008 | US20080305105 Bispecific antibodies |
| 12/11/2008 | US20080305104 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 12/11/2008 | US20080305103 Intraocular pressure-regulated early genes and uses thereof |
| 12/11/2008 | US20080305102 Therapeutic Agent for Cancer Comprising Substance Capable of Inhibiting Expression or Function of Synoviolin as Active Ingredient and Screening Method for the Therapeutic Agent for Cancer |
| 12/11/2008 | US20080305101 Methods and Compositions Related to Clot Binding Compounds |
| 12/11/2008 | US20080305081 Novel aminopyrimidine derivatives as PLK1 inhibitors |
| 12/11/2008 | US20080305075 Treatment of Hyperproliferative Diseases with Vinca Alkaloid N-Oxide and Analogs |
| 12/11/2008 | US20080305073 Therapeutic Agents for the Treatment of Hmgb1-Related Pathologies |
| 12/11/2008 | US20080305044 Engineered Antibodies and Immunoconjugates |
| 12/11/2008 | US20080305038 Transport of Nano-and Macromolecular Structures Into Cytoplasm and Nucleus of Cells |
| 12/11/2008 | CA2727126A1 Nasal-administered vaccines using multi-screened nalt-targeting and phagocytic polypeptide transport sequences |
| 12/11/2008 | CA2724432A1 Compositions and methods for binding lysophosphatidic acid |
| 12/11/2008 | CA2691039A1 Il-18 and protein kinase r inhibition for the treatment of copd |
| 12/11/2008 | CA2690848A1 Estrogen receptor-related receptor gamma (erry) in bone and cartilage formation and methods and compositions relating to same |
| 12/11/2008 | CA2689938A1 Compositions and methods for treating pancreatic tumors |
| 12/11/2008 | CA2689317A1 Antigen presenting cells |
| 12/11/2008 | CA2689302A1 Clostridial toxin netb |
| 12/11/2008 | CA2689242A1 Agent and method for treatment of cancer |
| 12/11/2008 | CA2688563A1 Cripto binding molecules |
| 12/11/2008 | CA2688268A1 Formulation of meningitis vaccines |
| 12/11/2008 | CA2687866A1 Anti-notch1 nrr antibodies and methods using same |
| 12/11/2008 | CA2687368A1 Vaccine for the prevention of breast cancer relapse |
| 12/11/2008 | CA2681183A1 Raccoon poxvirus expressing genes of feline antigens |
| 12/10/2008 | EP2000545A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/10/2008 | EP2000541A1 Humanized anti-cd20 monoclonal antibody |
| 12/10/2008 | EP2000536A2 Tat-derived transport polypeptides |
| 12/10/2008 | EP2000535A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 12/10/2008 | EP2000532A1 Methods of measuring human cytochrome P450 (CYP2C8/9) |
| 12/10/2008 | EP2000482A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/10/2008 | EP2000476A2 Immunogenic domains of SARS Coronavirus |
| 12/10/2008 | EP2000149A1 Chimeric anti-CD20 antibody |
| 12/10/2008 | EP2000148A1 Compositions and methods for the diagnosis and treatment of prostate cancer |
| 12/10/2008 | EP2000134A1 Use of a substance for the improvement of pns lesions |
| 12/10/2008 | EP2000026A1 Aseptic-anopheles-species insects, aseptic plasmodium-species sporozoites obtained therefrom and a vaccine comprising aseptic plasmodium-species sporozoites |
| 12/10/2008 | EP1999267A2 Methods of expressing gam-negative glycosaminoglycosaminoglycan synthase genes in gram-positive hosts |
| 12/10/2008 | EP1999152A1 Binding member for gm-csf receptor |
| 12/10/2008 | EP1999150A1 New protein isoforms and uses thereof |
| 12/10/2008 | EP1999148A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 12/10/2008 | EP1999147A1 Medical delivery device for therapeutic proteins based on single domain antibodies |
| 12/10/2008 | EP1999137A1 Synthetic archaeal glycolipid adjuvants |
| 12/10/2008 | EP1998810A2 Augmentation of endothelial thromboresistance |
| 12/10/2008 | EP1998807A2 Methods for humanizing antibodies and humanized antibodies made thereby |
| 12/10/2008 | EP1998806A1 Anti-igf-1r human monoclonal antibody formulation |
| 12/10/2008 | EP1998805A1 Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 |
| 12/10/2008 | EP1998804A1 Compositions comprising a recombinant adenovirus and an adjuvant |
| 12/10/2008 | EP1998803A2 Apparatus and method for vaccine development using ultrasound technology |
| 12/10/2008 | EP1998802A2 Immunogenic composition |
| 12/10/2008 | EP1998800A2 Compositions and methods related to staphylococcal bacterium proteins |
| 12/10/2008 | EP1998799A2 Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 12/10/2008 | EP1998796A2 Gdf-9/bmp-15 modulators for the treatment of bone disorders |
| 12/10/2008 | EP1998785A2 Hedgehog signaling pathway antagonist cancer treatment |
| 12/10/2008 | EP1998684A2 Triggered self-assembly conjugates and nanosystems |
| 12/10/2008 | EP1670820B1 Antigens for an east coast fever vaccine |
| 12/10/2008 | EP1606411B1 Mutant vesicular stomatitis viruses and use thereof |
| 12/10/2008 | EP1397122B1 Solid immunity adjuvant and vaccine containing the same |
| 12/10/2008 | EP1289549B1 The use of plant oil-bodies in vaccine delivery systems |
| 12/10/2008 | EP1274450B1 Medical uses of agonsist and antagonists of IL-174 |
| 12/10/2008 | EP1267921B1 Composition and method for the prevention and/or the treatment of der pii allergy |
| 12/10/2008 | EP1221964B1 Antigenic modification of polypeptides |
| 12/10/2008 | EP1220915B1 Splice variant of head trauma induced cytoplasmatic calcium binding protein |
| 12/10/2008 | EP1220913B1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 12/10/2008 | EP1212361B1 Preparation of highly pure non-toxic toxin fragments |
| 12/10/2008 | EP1163342B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/10/2008 | EP1021464B1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle |
| 12/10/2008 | EP1017791B1 Recombinant respiratory syncytial virus expression systems and vaccines |
| 12/10/2008 | EP1005494B1 High avidity polyvalent and polyspecific reagents |
| 12/10/2008 | EP0972054B1 Enhancement of immune response using targeting molecules |
| 12/10/2008 | CN101321861A Method for generating dendritic cells employing decreased temperature |
| 12/10/2008 | CN101321784A Nanobodies and polypeptides against EGFR and IGF-IR |
| 12/10/2008 | CN101321783A 人抗-b7rp1中和抗体 Human anti -b7rp1 neutralizing antibodies |
| 12/10/2008 | CN101321540A Interleukin-13 antibody composition |
| 12/10/2008 | CN101319201A Method for inducing malignant tumor cell apoptosis and uses thereof |
| 12/10/2008 | CN101319011A Multi-type HCV-E1 epitope complex immunogen, encoding gene and application thereof |
| 12/10/2008 | CN101319009A Slow Edwardsiella vaccine antigen and preparation method thereof |
| 12/10/2008 | CN101318019A Compositions and methods for the therapy of inflammatory bowel disease |
| 12/10/2008 | CN101318018A Application of anti-aFGF-scFv in preparing antineoplastic medicament and preparation method thereof |
| 12/10/2008 | CN101318017A Vaccine for preventing and/or treating allergic asthma |
| 12/10/2008 | CN101318016A Multivalent human-bovine rotavirus vaccine |
| 12/10/2008 | CN101318015A Senile dementia recombinant protein vaccine and preparation method thereof |
| 12/10/2008 | CN101318012A Application of beta-inhibited protein 1 in governing survival and autoimmunity of T cell |
| 12/10/2008 | CN100441689C EHEC 0157 shiga-like toxin IIA resisting subunit monoclonal antibody 5F3 light and heavy chain variable region gene and its application |
| 12/10/2008 | CN100441688C Lim mineralization protein splice variants |
| 12/10/2008 | CN100441241C Crosslinked hyaluronic acid compositions for tissue augmentation |
| 12/10/2008 | CN100441223C Human papilloma virus treatment |
| 12/09/2008 | US7462707 Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of Eimeria maxima and their uses |
| 12/09/2008 | US7462700 Vectors and host cells encoding and expressing canine RANKL polypeptide are provided, as well as antibodies that bind to RANKL and that inhibit RANKL activity |
| 12/09/2008 | US7462698 Anti-CD26 antibodies and methods of use thereof |
| 12/09/2008 | US7462697 Methods for antibody engineering |
| 12/09/2008 | US7462696 Human antibodies that have MN binding and cell adhesion-neutralizing activity |
| 12/09/2008 | US7462692 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides |
| 12/09/2008 | US7462691 Prostate stem cell antigen (PSCA) tumor antigen for use in diagnosis, prevention and treatment of prostate cancers |